Lars Grieten
Overview
Explore the profile of Lars Grieten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
648
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lanssens D, Vandenberk T, Storms V, Thijs I, Grieten L, Bamelis L, et al.
J Med Internet Res
. 2023 Sep;
25:e42686.
PMID: 37672324
Background: The peripartum period, defined as the period from the beginning of the gestation until 1 year after the delivery, has long been shown to be potentially associated with increased...
2.
Varma N, Cygankiewicz I, Turakhia M, Heidbuchel H, Hu Y, Chen L, et al.
Eur Heart J Digit Health
. 2023 Jan;
2(4):727.
PMID: 36716110
[This corrects the article DOI: 10.1093/ehjdh/ztab001.].
3.
Varma N, Cygankiewicz I, Turakhia M, Heidbuchel H, Hu Y, Chen L, et al.
Eur Heart J Digit Health
. 2023 Jan;
2(1):7-48.
PMID: 36711170
This collaborative statement from the International Society for Holter and Noninvasive Electrocardiology / Heart Rhythm Society / European Heart Rhythm Association / Asia Pacific Heart Rhythm Society describes the current...
4.
Varma N, Cygankiewicz I, Turakhia M, Heidbuchel H, Hu Y, Chen L, et al.
Cardiovasc Digit Health J
. 2022 Mar;
2(1):4-54.
PMID: 35265889
This collaborative statement from the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia Pacific Heart Rhythm Society describes the current status of mobile health ("mHealth") technologies...
5.
Lamberigts M, Van Hoof L, Proesmans T, Vandervoort P, Grieten L, Haemers P, et al.
JMIR Mhealth Uhealth
. 2021 Apr;
9(4):e26519.
PMID: 33856357
Background: Atrial fibrillation (AF) is the most common arrhythmia after cardiac surgery, yet the precise incidence and significance of arrhythmias after discharge home need to be better defined. Photoplethysmography (PPG)-based...
6.
Varma N, Cygankiewicz I, Turakhia M, Heidbuchel H, Hu Y, Chen L, et al.
J Arrhythm
. 2021 Apr;
37(2):271-319.
PMID: 33850572
This collaborative statement from the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia Pacific Heart Rhythm Society describes the current status of mobile health ("mHealth") technologies...
7.
Varma N, Cygankiewicz I, Turakhia M, Heidbuchel H, Hu Y, Chen L, et al.
Circ Arrhythm Electrophysiol
. 2021 Feb;
14(2):e009204.
PMID: 33573393
This collaborative statement from the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society describes the current status of mobile health technologies in arrhythmia...
8.
Varma N, Cygankiewicz I, Turakhia M, Heidbuchel H, Hu Y, Chen L, et al.
Ann Noninvasive Electrocardiol
. 2021 Jan;
26(2):e12795.
PMID: 33513268
This collaborative statement from the International Society for Holter and Noninvasive Electrocardiology/ Heart Rhythm Society/ European Heart Rhythm Association/ Asia Pacific Heart Rhythm Society describes the current status of mobile...
9.
Smeets C, Lee S, Groenendaal W, Squillace G, Vranken J, De Canniere H, et al.
JMIR Cardio
. 2020 Mar;
4(1):e12141.
PMID: 32186520
Background: Incomplete relief of congestion in acute decompensated heart failure (HF) is related to poor outcomes. However, congestion can be difficult to evaluate, stressing the urgent need for new objective...
10.
Smeets C, Storms V, Vandervoort P, Dreesen P, Vranken J, Houbrechts M, et al.
JMIR Cardio
. 2019 Nov;
2(1):e8.
PMID: 31758773
Background: European Society of Cardiology guidelines for the treatment of heart failure (HF) prescribe uptitration of angiotensin-converting enzyme inhibitors (ACE-I) and β-blockers to the maximum-tolerated, evidence-based dose. Although HF prognosis...